Zepp Health Corporation’s SEC filings document a foreign private issuer whose American depositary shares each represent sixteen Class A ordinary shares. The company files current reports on Form 6-K and annual reporting on Form 20-F covering its smart wearable and health technology business, including Amazfit-branded products and the Zepp Digital Management Platform.
The filings and exhibits record unaudited operating results, revenue and margin commentary, cash, inventory and loan balances, product launches, capital-structure actions, risk factors, governance matters and ADR-related disclosure. They also provide formal disclosure around periodic results releases and other material information furnished by the company to U.S. markets.
Zepp Health Corp executive Wang Hui, VP of Corporate Strategy, has filed an initial ownership report showing a substantial equity stake. He directly holds 1,495,500 Class A ordinary shares and several option awards over additional Class A shares, each with a $0.0000 exercise price and expirations ranging from 2030 to 2034. These entries reflect existing holdings rather than new market purchases or sales.
Zepp Health Corp director and Chief Operating Officer Mike Yan Yeung filed an initial ownership report showing his holdings in the company. He reported Class A ordinary shares and separate holdings of American depositary shares (ADSs). Each ADS represents 16 Class A ordinary shares, according to the disclosure.
Zepp Health Corp insider Yu Pengtao, the company’s Chief Industrial Designer, filed an initial ownership report showing holdings of 108,491 American depositary shares. Each ADS represents 16 Class A ordinary shares, so this filing mainly establishes his existing equity stake rather than reporting a new trade.
Zepp Health Corp director and CEO Huang Wang filed an initial ownership report showing substantial holdings in the company. He indirectly owns 65,836,680 Class B ordinary shares through HHtech Holdings Limited, which is ultimately owned by a trust established for the benefit of Mr. Wang and his family members.
He also indirectly holds 237,500 American depositary shares (ADSs) through HHtech Holdings Limited and directly holds 60,076 ADSs. Each ADS represents 16 Class A ordinary shares, giving him significant economic exposure and voting influence over Zepp Health.
Zepp Health Corporation reported rapid growth for the fourth quarter and full year 2025, pairing strong sales momentum with narrower losses. Fourth quarter 2025 revenue reached US$85.2 million, up 43.0% year over year and 12.4% sequentially, while gross margin climbed to a record 40.4% from 36.8% a year earlier, helped by a richer Amazfit product mix and sustained pricing.
Despite higher selling, marketing and general administrative costs, including US$5.2 million in special provisions and brand/IP expenses, profitability improved. Adjusted operating loss in the quarter shrank to US$2.7 million from US$7.4 million, and net loss fell to US$11.0 million from US$36.9 million. For full year 2025, revenue rose 41.8% to US$258.9 million, with net loss reduced to US$40.1 million from US$75.7 million and adjusted net loss down to US$31.5 million from US$56.7 million. Cash and restricted cash totaled US$112.9 million at year-end, inventory was US$72.8 million, cumulative debt retired since 2023 reached US$58.2 million, and the company has repurchased US$16.2 million (about 2.2 million ADSs) under a buyback program extended through November 2026. Management guides first quarter 2026 revenue of US$50.0–55.0 million, implying 30% to 43% year-over-year growth.
Zepp Health Corp director Lam Sai Wai Alain filed an initial Form 3, which is a statement of beneficial ownership of the company’s securities. The filing does not report any buy or sell transactions and serves to formally register his insider ownership status with regulators.
Zepp Health Corp director Zhang HongJiang filed an initial statement of beneficial ownership on Form 3. The filing identifies him as a director of Zepp Health but does not report any share transactions or changes in ownership, serving as a baseline disclosure of his status as an insider.
FIL Limited and related entities have disclosed a significant stake in Zepp Health Corp. As of 12/31/2025, they report beneficial ownership of 10,012,096 Class A common shares, representing 8.7% of the class. These shares are held with sole power to dispose but no shared voting or dispositive power.
The filing notes that one or more other persons have rights to dividends or sale proceeds, including Fidelity Funds - China Focus, whose interest was 5,998,048 Class A shares, or 5.2% of the outstanding class as of 12/31/2025. The securities are stated as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Zepp Health.
Zepp Health Corp (ZEPP): Schedule 13G/A ownership update
Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen reported beneficial ownership of 8,777,008 Class A ordinary shares of Zepp Health, equal to 7.6% of the class, as of September 30, 2025. The position is held in the form of 548,563 ADSs, with each ADS representing 16 Class A ordinary shares.
The reporting persons have shared voting and dispositive power over 8,777,008 shares and no sole voting or dispositive power. They certified the securities were not acquired to change or influence control of the issuer.
Zepp Health Corporation was the subject of a Schedule 13G reporting passive beneficial ownership by Millennium-affiliated entities and Integrated Core Strategies.
Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported beneficial ownership of 6,634,592 Class A Ordinary Shares, representing 5.8% of the class, with shared voting and dispositive power and 0 sole power. Integrated Core Strategies (US) LLC reported beneficial ownership of 6,285,648 shares, or 5.5%, also with shared voting and dispositive power and none sole.
The certification states the securities were not acquired and are not held for the purpose of changing or influencing control. The CUSIP (98945L204) applies to the issuer’s American Depositary Shares, and each ADS represents 16 Class A Ordinary Shares.